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Summary: The use of a magnetic Separation agent in a modified radioimmunoassay for the non-collagenous
cross-linked region (NC1) of basement membrane collagen is described. The rabbit anti-NCl serum employed
in the assay revealed a binding behaviour similar to that reported recently (Mark et al. (1985) Eur. J. Biochem.
146, 555-562; Schuppan et al. (1986) J. Clin. Invest. 78, 241-248) with respect to the integrity of NC1-
disulphide bridges, affinity to NC1 subunits and lack of reactivity with other determinants of type IV collagen.
Immunoreactive serum NC1, which increased towards the end of gestation, showed a broad peak during the
second trimester of pregnancy. In preeclampsia, immunoreactive serum-NCl was slightly elevated.
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autoantibodies involved in Goodpasture's syndrome In this report we describe a modified NC1 radioim-
are reactive with monomer and dimer proteins iso- mun assay procedure using a magnetic immunopre-
lated by collagenase digestion ofglomerular basement cipitation agent. To characterize the NC1 antiserum
membranes. These antigens apparently resemble NC1 used in our experiments, we tested for the existence
J. Clin. Chem. Clin. Biochem. / Vol. 27,1989 / No. 3
164 Bieglmayer and Hofer: Non-collagenous domain of type IV Collagen in pregnancy and preeclampsia
of reaction patterns similar to those of antisera re-
cently described (l, 2). Furthermore, the concentra-
tion of immunoreactive serum NC1 was determined
during pregnancy. We were prompted to report this
data, since NC1 measurements from women with
preeclamptic Symptoms further support the hypoth-
esis that this disease is connected to an impairment
of basement membranes.
Materials and Methods
NCl Radio immunoassay
Purified NCl, radiolabeled NCl and the rabbit anti-placental-
NC1 serum (IV/8 K2BE, 1984) were generous gifts from the
Radiochemical Laboratory of Hoechst AG, Frankfurt, FRG
(NCl was isolated from human placenta (4) and was iodinated
with 125I Bolton Hunter reagent (15) yielding a specific radio-
activity of approximately 370 MBq/mg).
Several anti-rabbit antibodies were tested for their practicability
in the Separation step of the radioimmunoassay. Finally. a
magnetic immunoprecipitation agent (code # 22263, Serono,
Freiburg, FRG) was selected because of low non-specific bind-
ing and a convenient Separation procedure.
Components were dissolved in 140 rnmol/1 NaCl, 2 mmol/1 KC1,
0.42 mmol/1 Tween 20 and 7.5 mmol/1 Soerensen buffer pH 7.3.
Using purified NCl s Standard, concentrations ranged from
42 μg/l to 1.31 μg/l by geometric dilution. Concentration of the
radiolabeled NCl was 10 μg/l and the titre of the rabbit anti-
NC1 serum was l: 20 000. All incubations were carried out in
a cold room. Standards or samples (100 μΐ) were pipetted at
least in duplicate, then incubated with 50 μΐ of NCl antiserurn
for 18 hours. Radiolabeled NCl (50 μΐ) was coincubated for
an additional 7 hours, followed by addition of 200 μΐ of a
Suspension of the Separation agent in assay buffer. Settling of
particles was avoided by shaking the tubes during incubation
for one hour. Pellets obtained by magnetic Separation were
washed once with 800 μΐ buffer. Radioactivity was counted with
a Packard Multiprias Gamma Scintillation Counter and the
data were evaluated by a weighted 4 parameter logistic model.
Characterisation of the rabbit anti-NCl serum
Purified placental NCl (Hoechst) was modified by partial re-
duction and carboxymethylation (16). NCl and reduced NCl
were analysed by sodium dodecylsulphate electrophoresis in
12% polyacryamide gels without 2-mercaptoethanol in the sam-
ple buffer (17). Proteins were either silver-stained (18) or were
blotted to a nitrocellulose membrane (Bio-Rad, USA) at 16 V
for 20 hours using a Bio-Rad Transblot-cell filled with 30
mmol/1 borate buffer pH 8.9. The membrane was blocked with
30 g/l bovine serum albumin for 3 hours and was further
incubated overnight with rabbit anti-NCl serum (l: 2000 di-
luted with radioimmunoassay buffer containing 10 g/l albumin).
After intensive washing with buffered physiological saline, the
membrane was incubated with 125I-labelled anti-rabbit IgG
(about 200000 counts/min -ml in radioimmunoassay buffer;
Amersham, UK) for one hour. Autoradiography of the washed
and dried membrane was performed with a Hyperfilm-MP
(Amersham). Specifity of the reaction was demonstrated by
omitting the anti-NCl serum, which resulted in a loss of dark-
ening on the film.
Human glomerular basement membranes served s a source
for the isolation of NCl according to a procedure described by
Wieslander & Heinegard for crude Goodpasture antigen (19).
Briefly, glomerular basement membranes were prepared (8),
then digested with collagenase (CLSPA, Worthington, K).
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Fig. 1. Elution of glomerular NCl from CM 52-cellulose by a
NaCl gradient.
The clarifled digest was subjected to ion exchange chromatOr
graphy on diethylaminoethyl-cellulose (DE-52, Whatman, UK)
in 8 mol/l urea buffered to pH 7.5. The eluted proteins were
applied to a carboxymethyl-cellulose column (CM-52, What-
man) in 8 mol/l urea buffered to pH 4.8. Glomerular NCl
(known to contain Goodpasture antigens) was eluted in a broad
inhomogeneous peak by a gradient of 0—0.3 mol/l NaCl (flg.
1). Fractions A—D were diluted with a lO^fold volume pf 10
mmol/1 sodium acetate in ethanol. Fraction A apparently con-
tained impurities and did not form a precipitate. Precipitates
from fractions B^-D were analysed by sodium dodecylsulphate
electrophoresis. To test for their competitive capacity in the
NCl radioimmunoassay, precipitates were also dissolved in
radioimmunoassay buffer. The relative protein content of the
fractions was estiraated by planimetry of the area <below the
absorbance curve. Type IV collagen was prepared from human
placenta by pepsin digestion (16). Various concentrations of the
collagen were dissolved in radioimmunoassay buffer to test for
competitive capacity in the NCl-radioimmunoassay.
Serum samples
Radioimmunoassay of immunoreactive NCl was perfprmed
with serum samples collected from 150 women with an uncom-
plicated course of pregnancy and from 9 patients with pre-
eclamptic Symptoms (gestosis index > 4; all of these patients
were hypertensive, oedema was diagnosed in 7 patients and
proteinuria in 4 patients). Within each assay we analysed 20
replicates of a serum pool of 30 healthy, nonpregnant women.
In the actual assay, NCl concentrations f pregnancy sera were
related to the mean concentration of the pool (defined s one
arbitrary unit/ml).
Results
NCl radioimmunoassay
Maximal bindirig of radiolabeled NCl to diluted rab-
bit anti-NCl serum was about 40% of total radio-
activity. Half maximal Inhibition was observed at a
NCl concentratiori of approximately 25 μ§/1. The
non-specific binding was 3%.
The suitability of the NCl radioimmunoassay for
human serum samples was tested. Serurn did not
influence the non-specific binding and competed in a
dose-dependent manner with the binding of radiola-
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Fig. 2. Linearity of dilution of human sera in the NC1 radio-
immunoassay (3 samples of non-pregnant women).
Half-maximal Inhibition of binding was achieved with
2.5 ng placental NC1 per assay.
beled NC1. Linearity of dilution of serum samples
was satisfactory at least between 3 and l ng NC1 per
incubation (fig. 2). Usually, a four-fold dilution was
sufficient for the analysis of serum samples at the
maximal slope of the calibration curve.
The serum matrix did not influence the recovery of
placental NC1: a serum sample, showing competition
equivalent to 48.4 ±1.6 μg/l NC1 (6 replicates, intra-
assay coefficient of Variation: 3%), was four-fold di-
luted and various concentrations of placental NC1
were added. The recovery of added NC1 was calcu-
lated after subtraction of the serum contribution
(tab. 1).
Tab. l. Recovery of placental NC1 within a serum matrix.
NC1 μg/l added to serum
31.5
15.8
7.9
3.9
2
Recovery (%)
100
113
97
100
105
The Variation between 15 assays was 17%. However,
the inter-assay Variation was reduced to 12% by nor-
malisation of the results to the average eoricentf ation
of replicates from a serum pool, which were measured
within the same assay.
Properties of the rabbit anti-NCl serum IV/8
K2BE
Binding behaviour of anti-NCl serum to reduced
placental NC1 was tested by electrophoresis and
Western blot analysis. Although monomers increased
in partly reduced NC1 (fig 3, compare lane l and 6),
we observed in Western blots only a weak binding of
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Fig. 3. Sodium dodecylsulphate electrophoresis and Western
blots of placental NC1.
Electrophoresis: lane l (NC1) and lane 6 (reduced NC1)
Western blot analysis: lane 2 and 3 (20 μg and 2.5 μg
NC1, respectively), lane 4 and 5 (5 μg and 20 μg reduced
NC1, respectively).
anti-NCl to reduced monomers. In addition, binding
to reduced dimers was also diminished (lanes 2, 3 and
4, 5; note that line 4 contained twice s much protein
s line 3).
The competitive capacity of NC1 subunits obtained
by dissociation of the globulin with urea was tested
in the NC1 radioimmunoassay. Fractions from col-
lagenase-digested glomerular basement membranes
(19) were used, since monomers and dimers were
partly separated by carboxymethyl-cellulose chro-
matography (fig. 1) s shown by electrophoresis of
fractions B —C (fig. 4). Fraction B contained predom-
inately monomer forms and fractions C and D were
rieh in dimers. Considering the protein content, these
latter fractions had a higher competitive capacity in
the NC1 radioimmunoassay than the monomer frac-
tion B (tab. 2).
Tab. 2. Relative protein content (A28onm) and relative immuno-
reactive NC1 content of fractions from CM 52-cellulose
chromatography (fig. 1).
Fraction
Protein
Immunoreactive NC1
B C D
4: 5:1
1:10:1
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Fig. 4. Sodium dodecylsulphate electrophoresis of fractions ob-
tained by CM-cellulose chromatography (see fig. 1).
Lane 1: protein mixture before chromatography. Lane
2: fraction\B, lane 3: fraction C, lane 4: fraction D.
Lane 5: Ovalbumin and carbonic anhydrase were used
äs protein Standards.
Serum NC1 may be linked to type IV collagen Frag-
ments (13, 14). To test wether the anti-NCl serum
cross-reacts with other determinants of the Collagen,
we used a pepsin-extracted type IV collagen prepa-
ration (16) lacking NC1 for displacement experiments.
Event at a 500-fold molar excess of collagen, no
Inhibition was detectable.
Concentrations of immunoreactive NC1 in
pregnancy
During the second trimester of pregnancy the serum
concentrations of immunoreactive NC1 increased to
values about 1.4-fold above those of non-pregnant
women (fig. 5). Levels dropped with onset of the third
trimester, but an additional increase was noticed to-
ward end of pregnancy. The mean serum cpricentra-
tion of patients with preeclamptic Symptoms was
slightly elevated.
Discussion
Information on basement membrane turnover in an-
imals and men may be derived from radioimmunol-
ogic measurements of fragments from its macromp-
lecular components (2, 13, 14, 20, 21). Cross-linked
regions of type IV collagen like NC1 or 7S (3) seem
to be suitable for this purpose, since they are involved
in the formation of collagen structures, and their
antigenicity facilitates preparation of specific antisera.
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Fig. 5. Serum concentrations of immunoreactive serum NC1
during pregnancy. Mean + Standard error mean were
calculated from three weekly intervals (about 15 women
per interval) and from patients with preeclamptic syinp-
toms (o).
The use of a magnetic Separation agent in the NC1
radioimmunoassay imprpved the assay procedure,
since immunoprecipitates often form fluffy pellets
(own observations). The assay was suitable for con^
centration measürements in human sera äs shown by
dilution and recovery experiments (fig. 2, tab. 1),
although Inhibition curves showed some nonparallel-
ity especially at high and low concentrations of serum
inhibitor (not shown).
The concentration of placeiital NC1 necessary for a
half maximal Inhibition was higher in our assay coim-
pared with former methods; but we obtained half
maximal Inhibition with about 40 of normal human
serum (fig. 2), whereas other investigators reported
about 100 (l, 2).
The properties of the anti-NCl serum IV/8 K2BE
were similar to those reported for other NC1 ^ antisera
(l, 2, 7), with respect to diminished reactivity with
reduced NC1 (fig. 3), monomers (tab. 2) and lack of
cröss-reaction with other domains of type IV collagen.
Some properties of these antisera may complicate
Interpretation of radioimmunoassay results. The high
molecular weight of immunofeactive serum NC1 in
rats indicated a link to collagen chains (13, 14), but
in men suffering from fibrotic liver disease, the frag-
ments detected were mainly similaf in size to NC1
subunits (2). Escape of type IV collagen molecules
during the synthesis of the network, äs well äs de-
gradation, may explain these findings (14). Since the
molecular forms of the antigen (intact globular struc-
ture, subunits, linked to collagen fragments) are
widely unknown in different human serum samples,
and the affinity of the antiserum apparently depended
on the integrity of disülphide bridges and on the
monprner/dimer ratio, all these factors may influence
J. Clin. Chem. Clin. Bioohem. / Vol. 27,1989 / No. 3
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radioimmunoassay results. It cannot be excluded that
apparent serum concentrations mainy reflect a bulk
of NC1 dimers and oligomers partly linked to type
IV collagen fragments and that enhanced dissociation
and degradation to monomers (which are not so well
detected) cause an underestimation of concentrations.
Thus, in our study on serum samples only imnrnno-
reactive NC1 was measured and we decided to express
concentrations relative to a pool of healthy, non-
pregnant women.
The complicated course of immunoreactive serum
NC1 during pregnancy may be related to placental
development (fig. 5). Although the placenta has at-
tained its definitive form and thickness during the
first trimester of pregnancy, growth in circumference
continues to the end of pregnancy. During the second
trimester important morphologic changes occur: the
placental villi increase in number, their stroma be-
comes more compact and is now separated from the
trophoblast by a distinct basement membrane (22). It
is possible that these morphological changes are re-
flected by the transitory increase of immunoreactive
serum NC1 during the second trimester, while the
increase of concentration toward the end of pregnancy
may result from further placental growth. Recently
we observed a similar increase of immunoreactive
laminin toward the end of pregnancy, but there was
no peak during the second trimester (20).
Preeclampsia represents a rare but severe risk for the
life of pregnant women and is often connected to
placental and renal injury. The aetiology is unknown.
But äs in the case of laminin (20), immunoreactive
NC1 tended to be elevated in patients with preeclamp-
tic Symptoms (fig. 5). Concentration changes of these
Parameters may reflect degradation äs well äs an
enhanced basement membrane synthesis, due to an
impaired functional integrity of the membranes. The
latter may be concordant with the characteristic thick-
ening of trophoblast basement membranes detected
in preeclamptic placentas (23). Combined observa-
tions, together with recent findings on circulating
serum antibodies against laminin and type IV collagen
in preeclampsia (24, 25), further support the hypoth-
esis of an involvement of basement membranes and
antibodies in the pathophysiology of this disease.
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